Ad
related to: inspire sleep breathing video commercial
Search results
Results From The WOW.Com Content Network
Medicare may cover Inspire, a device to treat sleep apnea, if it is medically necessary. A doctor needs to demonstrate that people meet certain criteria and CPAP therapy has been ineffective.
The typical screening process for sleep apnea involves asking patients about common symptoms such as snoring, witnessed pauses in breathing during sleep and excessive daytime sleepiness. [19] There is a wide range in presenting symptoms in patients with sleep apnea, from being asymptomatic to falling asleep while driving. [ 19 ]
Sleep surgery is a surgery performed to treat sleep disordered breathing. Sleep disordered breathing is a spectrum of disorders that includes snoring, upper airway resistance syndrome, and obstructive sleep apnea. These surgeries are performed by surgeons trained in otolaryngology, oral maxillofacial surgery, and craniofacial surgery.
The implant may be configured to best accommodate the patient's comfort and sleeping habits (e.g., set a delay based on sleep latency). The hypoglossal nerve stimulator implantable pulse generator battery life typically lasts 8–12 years, after which the implantable pulse generator may be safely replaced with another surgery.
Inspire Medical Systems Inc (NYSE: INSP ) has announced UnitedHealth Group Inc (NYSE: UNH ) will cover its Inspire Therapy for the treatment of obstructive sleep apnea beginning Aug. 1. “We are ...
Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity ...
Earlier in 2020, Inspire data was cited in a BJU International research paper about the effect of prostate cancer on sleep. [11] In January 2021, Marina Ness, Inspire's Director of Research, was an author on a paper [12] in European Urology Open Science, the Open Access journal of the European Urology family.
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...